Pharmacogenetics in Primary Headache Disorders [PDF]
Frontiers in Pharmacology, 2022 Primary headache disorders, such as migraine, tension-type headache (TTH), and cluster headache, belong to the most common neurological disorders affecting a high percentage of people worldwide. Headache induces a high burden for the affected individuals
Irina I. Belyaeva +11 more
doaj +4 more sources
Editorial: Cognitive schemas in primary headache disorders [PDF]
Frontiers in Neurology, 2023 Aynur Özge +5 more
doaj +4 more sources
Primary headache disorders: From pathophysiology to neurostimulation therapies [PDF]
Heliyon, 2023 Primary headache disorders including migraine, cluster headache, and tension-type headache are among the most common disabling diseases worldwide. The unclear pathogenesis of primary headache disorders has led to high rates of misdiagnosis and limited ...
Ziying Wang +3 more
doaj +2 more sources
Status of diagnosis and preventative treatment for primary headache disorders: real-world data of unmet needs in China [PDF]
The Journal of Headache and Pain, 2023 Background Headache disorders are widely prevalent and pose a considerable economic burden on individuals and society. Globally, misdiagnosis and inadequate treatment of primary headache disorders remain significant challenges, impeding the effective ...
Huanxian Liu +44 more
doaj +2 more sources
Comorbidities of primary headache disorders: a literature review with meta-analysis [PDF]
The Journal of Headache and Pain, 2021 Background Primary headache disorders are common and burdensome conditions. They are associated to several comorbidities, such as cardiovascular or psychiatric ones, which, in turn, contribute to the global burden of headache. The aim of this study is to
Valeria Caponnetto +17 more
doaj +2 more sources
Primary headache disorders: Five new things. [PDF]
Neurol Clin Pract, 2019 To review 5 new areas in primary headache disorders, especially migraine and cluster headache.Calcitonin gene-related peptide (CGRP) receptor antagonists (gepants-rimegepant and ubrogepant) and serotonin 5-HT1F receptor agonists (ditans-lasmiditan) have completed phase 3 clinical trials and will soon offer novel, effective, well-tolerated ...
Goadsby PJ.
europepmc +5 more sources
The prevalence and associated factors for primary headache disorders in adolescents in eastern Sudan: a community-based cross-sectional study [PDF]
Frontiers in NeurologyBackgroundHeadache disorder is the second-highest cause of disability worldwide; however, data are scarce on headache among adolescents, especially in Africa.
Saeed M. Omar +5 more
doaj +2 more sources
Patterns of Past COVID‐19 and EBV Infection in Primary Headache Disorders: A Population Study [PDF]
Brain and BehaviorIntroduction Viral illnesses are known to trigger chronic headaches. Following the COVID‐19 (coronavirus disease 2019) pandemic, many patients reported prolonged headaches.
Keshet Pardo +2 more
doaj +2 more sources
Primary headache disorders and neuro-ophthalmologic manifestations
Eye and Brain, 2012 Daniel P Schwartz, Matthew S RobbinsDepartment of Neurology, Montefiore Headache Center, Albert Einstein College of Medicine, Bronx, NY, USAAbstract: Headache is an extraordinarily common complaint presenting to medical practitioners in all arenas and ...
Schwartz DP, Robbins MS
doaj +4 more sources
Prevalence and Burden of Primary Headache Disorders in Kuwaiti Children and Adolescents: A Community Based Study [PDF]
Frontiers in Neurology, 2019 Background/Objective: Primary headaches are common in the pediatric and adolescent population and can be disabling for them and their families. We aimed to assess the prevalence and burden of primary headache disorders among children and adolescents in ...
Jasem Yousef Al-Hashel +4 more
doaj +2 more sources